Stay updated on HOPE-B: AMT-061 Clinical Trial
Sign up to get notified when there's something new on the HOPE-B: AMT-061 Clinical Trial page.

Latest updates to the HOPE-B: AMT-061 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe footer now displays Revision: v3.4.2, replacing Revision: v3.4.1. This appears to be a minor system update with no impact on study content or user actions.SummaryDifference0.0%

- Check18 days agoChange DetectedPublications section updated: added the NEJM article 'Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B' (N Engl J Med, 2026 Jan 29; DOI 10.1056/NEJMoa2514332) and removed the NEJM article 'Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B' (Dec 7, 2025).SummaryDifference0.1%

- Check33 days agoChange DetectedAdded UI toggles for glossary (Show glossary, Hide glossary). Updated metadata: Last Update Submitted that Met QC Criteria and No FEAR Act Data appear with revision to v3.4.0; older wording Last Update Submitted that met QC Criteria and No FEAR Act data were removed.SummaryDifference0.2%

- Check40 days agoChange DetectedVersion metadata updated from v3.3.3 to v3.3.4. No visible study details or content appear to be changed.SummaryDifference0.0%

- Check68 days agoChange DetectedThe Locations section now lists trial sites across multiple states and countries. Previous location blocks were removed, and the revision is updated to v3.3.3.SummaryDifference1%

- Check76 days agoChange DetectedAdded a new Publications entry: 'Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B. N Engl J Med. 2025 Dec 7. doi: 10.1056/NEJMoa2514332.'SummaryDifference0.0%

Stay in the know with updates to HOPE-B: AMT-061 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HOPE-B: AMT-061 Clinical Trial page.